Seizure of COVID Treatments Highlights IP Gaps in the United States-Mexico-Canada Agreement

Federal authorities seized at U.S. airports unauthorized versions of the COVID-19 treatment remdesivir destined for distribution in Mexico.[1]  Counterfeit versions are arriving in the U.S. by plane from Bangladesh and India and then smuggled by individuals to Mexico, which will then be sold to the highest bidder.[2]  The seizure of counterfeit treatments is not new as U.S. Customs and Border Protection officers have captured more than 100 shipments.[3]